Hovione has successfully passed a GMP and Postmarket Approval inspection by the FDA at its plant in Loures, Portugal. The inspection lasted five days and concluded September 27th with no Form 483 issued. The inspector was satisfied with Hovione’s GMP System, inspection organization, and its team members.   “We are pleased to have another successful FDA inspection at our Loures plant completed,” said Guy Villax, Hovione’s chief executive officer. “Doing well in the eyes of an FDA insp...